Related Experiment Videos
Pre-hospital thrombolysis: current status and future prospects
Journal of the Royal College of Physicians of London
|October 1, 1991
Summary
Pre-hospital thrombolysis for acute myocardial infarction shows time gains but lacks clear clinical benefit. Coordinated care policies are needed, and widespread use by GPs requires caution due to unproven benefits and risks.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Thrombolytic therapy is standard for acute myocardial infarction (AMI).
- Pre-hospital thrombolysis aims to reduce ischemic time and improve cardiac function.
- Early trials show time savings but lack definitive clinical benefit evidence.
Purpose of the Study:
- To review the rationale and evidence for very early thrombolysis in AMI.
- To assess the impact of small-scale studies on coronary patency, ventricular function, and infarct size.
- To examine the potential risks and benefits of pre-hospital thrombolysis.
Main Methods:
- Review of existing literature on pre-hospital thrombolysis for AMI.
- Analysis of pathophysiological mechanisms underlying early reperfusion.
- Evaluation of data from small-scale studies and ongoing large-scale trials.
Main Results:
- Pre-hospital thrombolysis can achieve significant time gains (up to 60 minutes).
- Evidence for improved clinical outcomes remains limited despite potential benefits in patency and infarct size.
- Risks associated with early administration require careful consideration.
Conclusions:
- Coordinated management policies involving primary care, EMS, and cardiac units are essential for AMI.
- Widespread use of thrombolytics by general practitioners without ECG confirmation is not supported by current evidence.
- Further evaluation of hospital triage and large-scale pre-hospital thrombolysis trials is warranted.